Canaccord Genuity Downgrades Xylem (XYL) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
DA Davidson Downgrades Xylem (XYL) to Underperform
July 31, 2013 2:37 PM EDTDA Davidson downgraded Xylem (NYSE: XYL) from Neutral to Underperform with a price target of $23.00 (from $28.00).
For an analyst ratings summary and ratings history on Xylem click here. For more ratings news on Xylem click here.
Shares of Xylem closed at $25.54 yesterday, with a 52 week range of $22.43-$29.79.... More
Wedbush Downgrades Xylem (XYL) to Neutral
July 31, 2013 6:56 AM EDTWedbush downgraded Xylem (NYSE: XYL) from Outperform to Neutral with a price target of $27.00 (from $32.00).
For an analyst ratings summary and ratings history on Xylem click here. For more ratings news on Xylem click here.
Shares of Xylem closed at $25.54 yesterday, with a 52 week range of $22.43-$29.79.... More
Atlantic Equities Downgrades Xylem (XYL) to Neutral
July 31, 2013 6:55 AM EDTAtlantic Equities downgraded Xylem (NYSE: XYL) from Overweight to Neutral.
For an analyst ratings summary and ratings history on Xylem click here. For more ratings news on Xylem click here.
Shares of Xylem closed at $25.54 yesterday, with a 52 week range of $22.43-$29.79.... More
BB&T Capital Downgrades Xylem (XYL) to Hold
July 30, 2013 1:28 PM EDTBB&T Capital downgraded Xylem (NYSE: XYL) from Buy to Hold.
For an analyst ratings summary and ratings history on Xylem click here. For more ratings news on Xylem click here.
Shares of Xylem closed at $28.46 yesterday, with a 52 week range of $22.43-$29.79.... More
Brean Capital Downgrades Xylem (XYL) to Hold
July 30, 2013 9:09 AM EDTBrean Capital downgraded Xylem (NYSE: XYL) from Buy to Hold. The downgrade follows disappointing Q2 results.
"Xylem's 2Q13 EPS results and 2013 guidance revisions have changed our investment thesis on the name. Adjusted EPS of $0.36 was well below consensus of $0.44, and the new full... More
Xylem, Inc. (XYL) Misses Q2 EPS by 8c; Trims FY13 EPS Views
July 30, 2013 7:18 AM EDTXylem, Inc. (NYSE: XYL) reported Q2 EPS of $0.36, $0.08 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $960 million versus the consensus estimate of $967.9 million.
Sees FY2013 EPS of $1.40-$1.50, versus prior guidance of $1.79-$1.89 and the consensus of $1.82. Sees... More
